The GS Verde Group is delighted to have advised a group of leading surgeons on its acquisition of a limited company involved in tissue sample research.

The London-based NHS spinout provides hospitals, medical researchers, academic groups, universities, and more with access, use and transfer of human tissue, organs and cells.

The use of samples in private and public sector research plays an important role in progressing new treatments and diagnoses for patient benefit. The success of using tissue samples to develop diagnostics and vaccines can be seen throughout the Covid-19 pandemic.

GS Verde's multidiscipline deal-making team has built a strong reputation for corporate transactions within technological and innovative fields such as biotechnology and life sciences.

The Group advised throughout the entire process, including structuring and negotiation through to completion, as part of its unique 'one team' approach to dealmaking.

Combining legal, tax, finance, and communications, the GS Verde Group are the business-focused experts in getting deals done.